Literature DB >> 8503535

Brain injury and repair mechanisms: the potential for pharmacologic therapy in closed-head trauma.

B C White1, G S Krause.   

Abstract

Rotational acceleration from closed-head trauma produces shear-strain brain injury at the interface of gray and white matter. The initial injury is followed by progressive damage involving three key phenomena: progression of subtle focal axonal damage to axonal transection between six and 12 hours after injury, progressive development of tissue microhemorrhages between 12 and 96 hours after injury, and development of tissue and cerebral spinal fluid lactic acidosis that does not appear to be explained by trauma-induced tissue depolarization, activation of phospholipases and the release of free arachidonic acid, radical generation by metabolism of arachidonate, and lipid peroxidation with consequent membrane degradation and partial mitochondrial uncoupling. Because of terminal differentiation, neurons may have a limited membrane repair capability that might be stimulated by growth factors. Other potential therapeutic interventions include calmodulin inhibitors, iron chelators, and free radical scavengers.

Entities:  

Mesh:

Year:  1993        PMID: 8503535     DOI: 10.1016/s0196-0644(05)82737-4

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  3 in total

1.  Pulsatile shear stress leads to DNA fragmentation in human SH-SY5Y neuroblastoma cell line.

Authors:  D H Triyoso; T A Good
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

2.  Alteration of opioid peptide concentrations in the rat pituitary following survivable closed head injury.

Authors:  O O Grigoriants; S V Pravdenkova; B J Andersen; D M Desiderio
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

3.  Conditional, genetic disruption of ciliary neurotrophic factor receptors reveals a role in adult motor neuron survival.

Authors:  Nancy Lee; Rachel Robitz; Rebekah J Zurbrugg; Adam M Karpman; Ashley M Mahler; Samantha A Cronier; Rachel Vesey; Rachel P Spearry; Sergei Zolotukhin; A John Maclennan
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.